Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Hengjin Pharmaceutical is a Chinese pharmaceutical company headquartered in Meihekou, Jilin Province, specializing in the development, manufacturing, and commercialization of Traditional Chinese Medicine (TCM) and chemical drugs. The company focuses primarily on therapeutic areas such as rheumatology, orthopedics, and cardiovascular health. Its flagship products include Yishen Juanbi Pills, which are used for treating rheumatoid arthritis and joint pain, and Compound Chondroitin Sulfate Capsules for osteoarthritis. Jilin Hengjin operates large-scale manufacturing facilities that adhere to national GMP standards and maintains a robust distribution network across China. The company integrates research and development with industrial production to provide specialized treatments for chronic bone and joint diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Hengjin Pharmaceutical.